Summary of - Current Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review
Document Type
Article
Abstract
Study background: The research presented titled “Current Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review” by Anna Mathew, Vignesh Balaji, Sreedhara Ranganath K. Pai, Anoop Kishore, Vasudev Pai, Ramadevi Pemmireddy, Chandrashekar. K. S as the etiology of AD is complex with a substantial portion of sporadic AD emerging from unknown reasons and a lesser proportion of early-onset familial AD (FAD) caused by mutation in several genes, such as the amyloid precursor protein (APP), presenilin 1 (PS1) and presenilin 2 (PS2) genes. Research goals and Hypotheses: The primary goal was to summarizes the possible drug targets and related pathophysiological mechanisms for the treatment of Alzheimer’s associated memory impairment. Methodological Approach: The present review provides an insight into the possible therapeutic strategies and their molecular mechanisms enlightening perception on classical and future treatment approaches.
Cite: Anna, M., Vignesh, B., Sreedhara, R. K. P, Anoop, K, Vasudev, P, Ramadevi, P., Chandrashekar, K. S., 2023. Current Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review. CNS and Neurological Disorders - Drug Targets, 22(2), pp. 255-275.
Publication Date
2023
Recommended Citation
Mathew, Anna; E, Vignesh Balaji; Pai, Sreedhara Ranganath K; Kishore, Anoop; Pai, Vasudev; Pemmireddy, Ramadevi; and K.S, Chandrashekar, "Summary of - Current Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review" (2023). Open Access archive. 9552.
https://impressions.manipal.edu/open-access-archive/9552
